Skip to Content

WPI 50 (Celecoxib 50 mg)

Pill with imprint WPI 50 is Pink & White, Capsule-shape and has been identified as Celecoxib 50 mg. It is supplied by Actavis Pharma, Inc..

Celecoxib is used in the treatment of pain; osteoarthritis; rheumatoid arthritis; ankylosing spondylitis; familial adenomatous polyposis (and more), and belongs to the drug class cox-2 inhibitors. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 50

Celecoxib 50 mg WPI 50

Celecoxib

Imprint:
WPI 50
Strength:
50 mg
Color:
Pink & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cox-2 inhibitors
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-3982

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide